Categories: Health

NTG Nordic Transport Group A/S – Q3 2025 Conference Call

 | Source: NTG Nordic Transport Group A/S

NTG Nordic Transport Group A/S – Q3 2025 Conference Call

We expect to release the Q3 2025 interim results of NTG Nordic Transport Group on the evening of November 10, 2025. A webcast and conference call will be held in the morning of November 11, 2025, at 10:00 am CET.

At the call, Group CEO Mathias Jensen-Vinstrup and Group CFO Christian D. Jakobsen will present the Q3 2025 Interim Financial Report. The presentation will be followed by a Q&A session.

Date: November 11, 2025
Time: 10:00 am CET

To attend the conference call, please go to: Conference Call – NTG Q3 2025 Interim Financial Report or Investors | NTG Nordic Transport Group.

If you wish to ask questions during the conference call, please register through this link: Conference Call Q&A – NTG Q3 2025 Interim Financial Report.

We recommend participants to dial in 10 minutes prior to the scheduled start time.

Contacts

Investor Relations
Sebastian Rosborg, tel. +45 42 12 80 99, sebastian.rosborg@ntg.com

Best regards,
NTG Nordic Transport Group A/S

GlobeNews Wire

Recent Posts

Oculis Publishes Notifications of Transactions by Persons Discharging Managerial Responsibilities and Persons Closely Associated

ZUG, Switzerland, Feb. 17, 2026 (GLOBE NEWSWIRE) -- Ms. Kazem brings extensive and global expertise…

2 weeks ago

Novartis Vanrafia Phase III data support slowing of kidney function decline in patients with IgA nephropathy

Basel, February 13, 2026 – Novartis today announced final results from the Phase III ALIGN…

3 weeks ago

January Commercial Chapter 11 Filings Increase 76% Over 2025

NEW YORK, Feb. 06, 2026 (GLOBE NEWSWIRE) -- There were 956 commercial Chapter 11 filings…

4 weeks ago

Novartis breaks ground on new global Biomedical Research center in San Diego to accelerate drug discovery

Basel, February 6, 2026 – Novartis today broke ground on a new, state-of-the-art global Biomedical…

4 weeks ago

Novartis ianalumab receives FDA Breakthrough Therapy designation for Sjgrens disease

Basel, January 16, 2026 – Novartis today announced that the US Food and Drug Administration (FDA)…

2 months ago

Personar Appoints Former Genius Sports COO Eric Stevens as Chief Operating Officer to Scale Award-Winning Sports Technology Platform

Tuesday 13 January, 2026 LONDON – Tuesday, January 13, 2026 – Personar, the AI sports…

2 months ago